Cargando…
Anticholinergic drugs and forebrain magnetic resonance imaging changes in cognitively normal people and those with mild cognitive impairment
BACKGROUND AND PURPOSE: Anticholinergic (AC) medication use is associated with cognitive decline and dementia, which may be related to an AC‐induced central hypocholinergic state, but the exact mechanisms remain to be understood. We aimed to further elucidate the putative link between AC drug prescr...
Autores principales: | Meng, Dewen, Mohammadi‐Nejad, Ali‐Reza, Sotiropoulos, Stamatios N., Auer, Dorothee P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304308/ https://www.ncbi.nlm.nih.gov/pubmed/35129272 http://dx.doi.org/10.1111/ene.15251 |
Ejemplares similares
-
Effect of APOE ε4 genotype on amyloid‐β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment
por: Li, Weihua, et al.
Publicado: (2022) -
Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia
por: Galgani, Alessandro, et al.
Publicado: (2022) -
European Academy of Neurology/European Alzheimer’s Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment
por: Frederiksen, Kristian Steen, et al.
Publicado: (2020) -
A nationwide survey of Italian Centers for Cognitive Disorders and Dementia on the provision of care for international migrants
por: Canevelli, Marco, et al.
Publicado: (2022) -
Protective factors for subjective cognitive decline individuals: trajectories and changes in a longitudinal study with Italian elderly
por: Mondini, Sara, et al.
Publicado: (2021)